Roadmap for America's Cancer Explorers for the 21st Century (Race 21)
21 世纪美国癌症探索者路线图(第 21 场比赛)
基本信息
- 批准号:10252847
- 负责人:
- 金额:$ 41.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-03 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAdultAdvanced Malignant NeoplasmAfricaAfrican AmericanAlabamaAmericanAmericasAreaAwarenessBiologyCancer BiologyCancer Death RatesCancer EtiologyClinical TrialsCommunicationCommunity OutreachComprehensive Cancer CenterDevelopmentEarly DiagnosisEarly treatmentEducationExposure toFamilyFellowshipFoundationsFuture GenerationsGeneral PopulationGoalsHealthHigh School FacultyHigh School StudentIndividualInstitutesInternshipsKnowledgeMainstreamingMalignant NeoplasmsMentorsMethodsMinorityModelingMorbidity - disease rateNCI Center for Cancer ResearchNext Generation Science StandardsParentsPathway interactionsPhasePositioning AttributePreventionProgram DevelopmentRaceResearchResearch PersonnelResearch TrainingResourcesSchoolsScienceScience, Technology, Engineering and MathematicsScience, Technology, Engineering and Mathematics EducationSecondary SchoolsStudentsTeacher Professional DevelopmentTestingTextTrainingUnderrepresented PopulationsUnderrepresented StudentsUniversitiesWorkYouthanticancer researchbasecancer health disparitycareercohortcommunity centerexperiencehigh schoolimprovedinnovationinterestmaleminority communitiesminority studentmortalitynext generationoutreachprogramsscience teacherskillssummer internshipsummer researchteachertwelfth gradeundergraduate studentunderrepresented minority studentuniversity student
项目摘要
Roadmap for America’s Cancer Explorers for the 21st Century (RACE21) is an interdisciplinary
program to develop a pipeline to a diverse 21st century cancer research workforce. Cancer is a
primary cause of adult mortalities in the US, despite excellent advances in understanding cancer
biology and innovative treatments. In Alabama, cancer is the 2nd highest cause of mortality, and
cancer death rates are almost double in Alabama’s African-American (compared to White) males.
One of the underlying causes of this anomaly is the lack of communication about cancer among
Africa-Americans, especially within families. Also, relatively few African-American youth are
seeking careers in cancer research, largely due to very little exposure to cancer biology in most
of their secondary schools and their teachers’ lack of cancer biology training. Further, few informal
programs excite students about careers in cancer biology. RACE21 will build an innovative and
effective pipeline to cancer research careers, especially for students underrepresented in cancer
research (URM) by building on 5-basic foundations: 1) The University of Alabama at Birmingham’s
(UAB) outstanding O’Neal Comprehensive Cancer Center, 2) Over 200 cancer researchers,
eager to mentor high school and college students to become the next generation of cancer
researchers, 3) development of an innovative Undergraduate Cancer Biology Major, 4) the Center
for Community OutReach Development (CORD), which will train high school biology teachers in
cancer research and introduce advanced high school students to cancer research in both formal
and informal settings and 5) training in communication about cancer. RACE21 employs successful
methods developed at UAB, and uses them to advance cancer biology education. The pipeline
starts with high school students being introduced to cancer biology through state-of-the-art
experiences in the Summer Science Institute (10 URM rising seniors will be Summer Research
Interns) and experiences at the GENEius lab. RACE21 will also provide intense cancer biology
training to high school teachers via an annual 3-week BioTeach-Cancer training. RACE21 students
(>80% URM) entering UAB’s new Cancer Biology Major will complete a paid summer internship
in cancer research in their rising year 1 and 2, and in year 3 and 4 they will receive fellowships as
cancer researchers. Each year 10 RACE21 students will complete the undergraduate major, with
most continuing to graduate school in cancer research related areas. The Intellectual Merit of
RACE21 will be in testing a pipeline that leads to increased minorities in cancer biology careers.
The Broader Impacts will annually educate about 6,000 minority students, families and the public
about cancer biology and launch the cancer research careers of >40 minority students.
21世纪美国癌症探索者路线图(Race21)是一个跨学科的
该计划旨在开发一条通往21世纪多元化癌症研究队伍的管道。癌症是一种
美国成人死亡的主要原因,尽管对癌症的理解取得了很大进展
生物学和创新疗法。在阿拉巴马州,癌症是第二大死亡原因,
阿拉巴马州非裔美国人(与白人相比)的癌症死亡率几乎是白人的两倍。
这种反常现象的根本原因之一是人们之间缺乏关于癌症的沟通
非洲裔美国人,特别是在家庭内部。此外,相对较少的非裔美国青年是
寻求癌症研究的职业,主要是因为大多数人对癌症生物学的接触很少
由于他们的中学和教师缺乏癌症生物学培训。此外,很少有非正式的
这些项目让学生们对癌症生物学的职业感到兴奋。Race21将构建一个创新和
通往癌症研究事业的有效渠道,特别是对癌症研究人数不足的学生
研究(URM)建立在5个基本基础上:1)阿拉巴马大学伯明翰分校
(UAB)杰出的奥尼尔综合癌症中心,2)200多名癌症研究人员,
渴望辅导高中生和大学生成为下一代癌症
研究人员,3)创新型本科肿瘤生物学专业的发展,4)中心
社区外展发展(CORD),它将培训高中生物教师
癌症研究和向高中生介绍癌症研究都是正规的
以及非正式的环境和5)关于癌症的沟通培训。Race21使用成功
方法在UAB发展,并利用它们来推进癌症生物学教育。这条管道
首先通过最先进的技术向高中生介绍癌症生物学
在暑期科学学院的经历(10名URM高年级学生将进行暑期研究
实习生)和在GENEIUS实验室的经验。Race21还将提供强烈的癌症生物学
通过每年3周的生物教学-癌症培训对高中教师进行培训。21届学生比赛
(>;80%URM)进入UAB新的癌症生物学专业将完成带薪暑期实习
在他们第一年和第二年的癌症研究中,在第三年和第四年,他们将获得奖学金
癌症研究人员。每年将有10名Race21学生完成本科专业,
大多数人继续在癌症研究相关领域研究生院学习。在智力方面的功绩
Race21将测试一条管道,该管道将导致癌症生物学职业生涯中少数族裔的增加。
更广泛的影响每年将教育大约6,000名少数民族学生、家庭和公众
关于癌症生物学,并启动>;40名少数民族学生的癌症研究事业。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lalita A. Shevde其他文献
Multi-faceted role of HSP40 in cancer
- DOI:
10.1007/s10585-009-9255-x - 发表时间:
2009-04-02 - 期刊:
- 影响因子:3.200
- 作者:
Aparna Mitra;Lalita A. Shevde;Rajeev S. Samant - 通讯作者:
Rajeev S. Samant
Emerging role of nuclear protein 1 (NUPR1) in cancer biology
- DOI:
10.1007/s10555-009-9183-x - 发表时间:
2009-01-20 - 期刊:
- 影响因子:8.700
- 作者:
Uttio Roy Chowdhury;Rajeev S. Samant;Oystein Fodstad;Lalita A. Shevde - 通讯作者:
Lalita A. Shevde
Informing the new developments and future of cancer immunotherapy
- DOI:
10.1007/s10555-021-09967-1 - 发表时间:
2021-05-18 - 期刊:
- 影响因子:8.700
- 作者:
Atul Kumar;Courtney A. Swain;Lalita A. Shevde - 通讯作者:
Lalita A. Shevde
Erratum to: ‘Hedgehog signaling: modulation of cancer properties and tumor microenvironment’
- DOI:
10.1186/s12943-016-0522-6 - 发表时间:
2016-05-11 - 期刊:
- 影响因子:33.900
- 作者:
Ann Hanna;Lalita A. Shevde - 通讯作者:
Lalita A. Shevde
The metastatic cascade through the lens of therapeutic inhibition
通过治疗性抑制视角看转移级联
- DOI:
10.1016/j.xcrm.2024.101872 - 发表时间:
2025-01-21 - 期刊:
- 影响因子:10.600
- 作者:
Ian Miranda;Nusrat Jahan;Lalita A. Shevde - 通讯作者:
Lalita A. Shevde
Lalita A. Shevde的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lalita A. Shevde', 18)}}的其他基金
Role of O-GlcNAc-ylation on tumor progression
O-GlcNAc 基化在肿瘤进展中的作用
- 批准号:
10589810 - 财政年份:2022
- 资助金额:
$ 41.79万 - 项目类别:
Role of O-GlcNAc-ylation on tumor progression
O-GlcNAc 基化在肿瘤进展中的作用
- 批准号:
10444126 - 财政年份:2022
- 资助金额:
$ 41.79万 - 项目类别:
Roadmap for America's Cancer Explorers for the 21st Century (Race 21)
21 世纪美国癌症探索者路线图(第 21 场比赛)
- 批准号:
10478045 - 财政年份:2020
- 资助金额:
$ 41.79万 - 项目类别:
Roadmap for America's Cancer Explorers for the 21st Century (Race 21)
21 世纪美国癌症探索者路线图(第 21 场比赛)
- 批准号:
10023708 - 财政年份:2020
- 资助金额:
$ 41.79万 - 项目类别:
Molecular determinants of breast cancer malignancy
乳腺癌恶性肿瘤的分子决定因素
- 批准号:
8458999 - 财政年份:2011
- 资助金额:
$ 41.79万 - 项目类别:
Molecular determinants of breast cancer malignancy
乳腺癌恶性肿瘤的分子决定因素
- 批准号:
8653835 - 财政年份:2011
- 资助金额:
$ 41.79万 - 项目类别:
Molecular determinants of breast cancer malignancy
乳腺癌恶性肿瘤的分子决定因素
- 批准号:
8261842 - 财政年份:2011
- 资助金额:
$ 41.79万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)